NCT02694913 Polymorphisms at Distinct Genetic Loci Affect Response to Anti-CD20 Monoclonal Antibody Therapies Status COMPLETED Phase N/A
NCT02690545 Study of CD30 CAR for Relapsed/Refractory CD30+ HL and CD30+ NHL Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT02682953 Hyperbaric Oxygen Therapy for Hematopoietic Progenitor Cell Collection in Poor Mobilizers Status WITHDRAWN Phase PHASE2
NCT02681302 Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence Status TERMINATED Phase PHASE1/PHASE2
NCT02663297 Administration of T Lymphocytes for Prevention of Relapse of Lymphomas Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02656147 Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL Status UNKNOWN Phase PHASE1
NCT02652468 TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma Status COMPLETED Phase NA
NCT02642510 Improving Patient Education for Lymphoma and Leukemia Inpatients Status COMPLETED Phase NA
NCT02624388 Study of Genistein in Pediatric Oncology Patients (UVA-Gen001) Status TERMINATED Phase PHASE2
NCT02608307 Medical Treatment Decision Making Using Adaptive Conjoint Analysis Status TERMINATED Phase N/A
NCT02605694 Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO) Status WITHDRAWN Phase PHASE2
NCT02601547 PET-based Evaluation of Chemotherapy-induced Brain Damage in Lymphoma Status COMPLETED Phase NA
NCT02598752 Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation Status COMPLETED Phase N/A
NCT02598570 Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory Lymphoma Status COMPLETED Phase PHASE1
NCT02595255 AMH as a Predictor of Infertility Risk in Children With Cancer (CHANCE) Status RECRUITING Phase N/A
NCT02593123 Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis Status COMPLETED Phase PHASE2
NCT02589145 Lenalidomide Combined With Vorinostat/Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation in Diffuse Large B-Cell Lymphoma of the ABC Subtype Status TERMINATED Phase PHASE1/PHASE2
NCT02588560 Viral Load Changes in Lymphoma Patients With HCV Infection After Chemotherapy Status UNKNOWN Phase N/A